PCCA Reaffirms Its Commitment to Compounding Quality and Safety with The PCCA Standard™
HOUSTON--(BUSINESS WIRE)--May 8, 2019--For more than 38 years, PCCA has been committed to providing the utmost quality and safety in compounding as an FDA-registered and -inspected chemical repackager and relabeler. Today, PCCA is reaffirming and further defining this commitment with the launch of The PCCA Standard™ and website at thepccastandard.com.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190508005139/en/
PCCA is reaffirming and further defining its commitment to quality and safety in compounding with the launch of The PCCA Standard™ and website at thepccastandard.com.
“Every day, we make a choice to define ourselves by high quality,” said PCCA President Jim Smith. “We want to do everything we can to help our customers give their patients reproducible results and the best clinical outcomes possible, because patients and compounding pharmacies matter to us. That’s why, every day, we choose to go above and beyond what is simply required and hold ourselves to The PCCA Standard.”
The new website explores how The PCCA Standard applies to the company’s sourcing of chemicals, quality assurance and quality control, base development and production, and formulations. Specifically, visitors will learn more about the PCCA API Manufacturer Qualification Program, which ensures that PCCA finds the best active pharmaceutical ingredient (API) manufacturer every time through its four-step process:
- Manufacturer Assessment
- Sample Testing
- PCCA Formula Testing
- Manufacturer Reassessment
An interactive operations facilities map shows website visitors the meticulous step-by-step evaluation of every chemical lot received, repackaged and shipped to customers from PCCA. Additionally, three videos reveal the development, production and quality of PCCA’s innovative proprietary bases. Finally, PCCA shares how The PCCA Standard applies to the formulas it develops and the science behind them.
“All of this effort mitigates risk and provides PCCA customers with confidence that the ingredients used to compound prescriptions for their patients are of the highest quality,” said PCCA Chief Scientific Officer Gus Bassani, PharmD. “There’s a lot of talk in the marketplace about quality products, but it is thin on substance. It’s one thing to say you sell quality products; it’s an entirely different thing to prove it by lifting the curtain on our proprietary processes to show the world the steps we take to ensure that we provide our customers only the best products.”
PCCA helps pharmacists and prescribers create personalized medicine that makes a difference in patients’ lives. As a complete resource for independent compounding pharmacists, PCCA provides high-quality products, education and support to more than 3,000 pharmacy members throughout the United States, Canada, Australia and other countries around the world. Incorporated in 1981 by a network of pharmacists, PCCA has supported pharmacy compounding for more than 38 years. Learn more at pccarx.com and thepccastandard.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190508005139/en/
Kim Speairs, APR, MBA, Director of Communications and Engagement, PCCA, 281.709.8277,email@example.com
KEYWORD: UNITED STATES NORTH AMERICA TEXAS
INDUSTRY KEYWORD: HEALTH ALTERNATIVE MEDICINE PHARMACEUTICAL OTHER HEALTH MANUFACTURING CHEMICALS/PLASTICS PACKAGING RESEARCH OTHER SCIENCE FDA SCIENCE
Copyright Business Wire 2019.
PUB: 05/08/2019 11:00 AM/DISC: 05/08/2019 11:01 AM